Stay updated on Semaglutide vs Placebo in PAD and T2D Clinical Trial
Sign up to get notified when there's something new on the Semaglutide vs Placebo in PAD and T2D Clinical Trial page.

Latest updates to the Semaglutide vs Placebo in PAD and T2D Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.4.2 was added to the record history. Revision: v3.4.1 was removed along with the government-funding lapse notice.SummaryDifference0.3%

- Check22 days agoChange DetectedA site-wide funding notice was added. Revision: v3.4.1 was introduced and the previous Revision: v3.4.0 was removed.SummaryDifference0.3%

- Check29 days agoChange DetectedUI updates on the history page introduce a glossary display and color-coded change highlights (green for additions, red for deletions) along with updated labels such as No FEAR Act data and revision notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check43 days agoChange DetectedRevision history updated from v3.3.3 to v3.3.4; this is an administrative update and does not alter the study's content or results.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision: v3.3.3 was added to the history. The footer now excludes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.1%

- Check72 days agoChange DetectedVersion 116 (2025-11-24) adds updates to the record by including Contacts/Locations and the current Study Status for NCT04560998. A prior entry dated 2025-07-08 was removed from the history.SummaryDifference0.2%

Stay in the know with updates to Semaglutide vs Placebo in PAD and T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide vs Placebo in PAD and T2D Clinical Trial page.